Get the Stockscreener App
7.96
1.27%
0.10
After Hours:
8.38
0.42
+5.28%
Vir Biotechnology Inc Stock (VIR) Forecast
The Vir Biotechnology Inc (VIR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $30.18, representing a +279.18% increase from the current price of $7.96. The highest analyst price target is $37.39, and the lowest is $22.98.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VIR Price Target
Average 78.43
(+885.28% Upside)
Is Vir Biotechnology Inc (VIR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.98 | Neutral |
| STOCH(9,6) | 40.63 | Neutral |
| STOCHRSI(14) | 45.11 | Neutral |
| MACD(12,26) | -0.1864 | Sell |
| ADX(14) | 23.06 | Neutral |
| William %R | -60.73 | Neutral |
| CCI(14) | -4.7368 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.366
Buy
|
7.7205
Buy
|
| MA20 |
8.4105
Sell
|
7.9085
Buy
|
| MA50 |
7.8936
Buy
|
8.0557
Sell
|
| MA100 |
8.3769
Sell
|
8.3468
Sell
|
| MA200 |
9.1178
Sell
|
8.8977
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, VIR could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on VIR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.98 indicates that VIR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.63 indicates that VIR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 45.11 indicates that VIR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.06 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -4.7368 indicates that VIR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VIR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vir Biotechnology Inc financial reports and earnings history, Vir Biotechnology Inc (VIR) stock could reach $43.81 by 2030, $7.7593 by 2040 and $5.8522 by 2050. See the projected annual prices until 2050 of the Vir Biotechnology Inc stock below:
- Vir Biotechnology Inc (VIR) is expected to reach an average price of $1.9819 in 2035, with a high prediction of $13.56 and a low estimate of $0.5406. This indicates an $-75.10% rise from the last recorded price of $7.96.
- Vir Biotechnology Inc (VIR) stock is projected to chart a bullish course in 2040, with an average price target of $7.1654, representing an $-9.98% surge from its current level. The forecast ranges from a conservative $8.4254 to a sky-high $7.7593.
- Our analysts predict Vir Biotechnology Inc (VIR) to jump 59.59% by 2045, soaring from $4.8856 to an average price of $12.70, potentially reaching $11.14. While $4.8856 is the low estimate, the potential upside is significant.
- Vir Biotechnology Inc (VIR) stock is expected to climb by 2050, reaching an average of $6.7022, a $-15.80% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8522 and $5.7227, respectively, highlighting the market's uncertainty.
Vir Biotechnology Inc Stock (VIR) Year by Year Forecast
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2025
Vir Biotechnology Inc Stock (VIR) is expected to reach an average price of $78.43 in 2025, with a high prediction of $136.29 and a low estimate of $20.57. This indicates an +885.28% rise from the last recorded price of $7.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $28.21 | $22.98 | $37.39 | +254.40% |
| February, 2025 | $36.00 | $27.71 | $45.77 | +352.25% |
| March, 2025 | $43.12 | $32.07 | $49.28 | +441.69% |
| April, 2025 | $36.74 | $34.87 | $50.08 | +361.50% |
| May, 2025 | $27.85 | $22.27 | $39.10 | +249.81% |
| June, 2025 | $36.04 | $25.68 | $38.09 | +352.82% |
| July, 2025 | $22.30 | $20.69 | $39.14 | +180.17% |
| August, 2025 | $26.61 | $20.63 | $28.04 | +234.31% |
| September, 2025 | $22.00 | $21.86 | $29.35 | +176.39% |
| October, 2025 | $62.01 | $20.57 | $136.29 | +678.98% |
| November, 2025 | $40.50 | $30.32 | $78.80 | +408.75% |
| December, 2025 | $44.92 | $37.49 | $63.52 | +464.36% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2026
The predicted value for Vir Biotechnology Inc (VIR) in 2026 is set at an average of $37.15. Estimates vary from a peak of $53.66 to a trough of $20.65, indicating an +366.77% surge from the present price of $7.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $43.12 | $37.90 | $46.59 | +441.74% |
| February, 2026 | $37.32 | $31.21 | $44.00 | +368.87% |
| March, 2026 | $40.95 | $36.47 | $45.44 | +414.47% |
| April, 2026 | $32.37 | $30.47 | $43.80 | +306.64% |
| May, 2026 | $41.98 | $30.10 | $44.61 | +427.36% |
| June, 2026 | $47.24 | $42.09 | $47.92 | +493.44% |
| July, 2026 | $32.66 | $28.18 | $50.14 | +310.29% |
| August, 2026 | $26.86 | $25.86 | $37.04 | +237.48% |
| September, 2026 | $39.95 | $25.13 | $48.48 | +401.89% |
| October, 2026 | $37.54 | $33.79 | $53.66 | +371.61% |
| November, 2026 | $29.67 | $25.18 | $37.53 | +272.73% |
| December, 2026 | $23.57 | $20.65 | $31.19 | +196.06% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vir Biotechnology Inc (VIR) is $20.87, with a high forecast of $27.69 and a low forecast of $14.04. This indicates an +162.16% increase from the last price of $7.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.89 | $17.09 | $23.43 | +174.95% |
| February, 2027 | $17.97 | $16.31 | $23.26 | +125.69% |
| March, 2027 | $18.46 | $14.04 | $20.29 | +131.94% |
| April, 2027 | $20.92 | $17.89 | $22.66 | +162.83% |
| May, 2027 | $21.36 | $17.58 | $23.51 | +168.35% |
| June, 2027 | $23.74 | $21.08 | $27.69 | +198.21% |
| July, 2027 | $20.36 | $20.06 | $27.09 | +155.74% |
| August, 2027 | $16.01 | $15.51 | $21.03 | +101.09% |
| September, 2027 | $17.26 | $14.04 | $18.41 | +116.88% |
| October, 2027 | $23.40 | $16.85 | $24.06 | +194.01% |
| November, 2027 | $23.69 | $22.61 | $24.49 | +197.64% |
| December, 2027 | $22.17 | $20.65 | $23.68 | +178.51% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2028
In 2028, Vir Biotechnology Inc (VIR) is projected to reach an average price of $15.95, with a high projection of $27.69 and a low estimate of $4.2002. This indicates an +100.32% rise from the last price of $7.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.70 | $21.65 | $27.69 | +222.85% |
| February, 2028 | $19.17 | $18.20 | $27.11 | +140.87% |
| March, 2028 | $18.71 | $18.23 | $20.67 | +134.99% |
| April, 2028 | $22.22 | $18.55 | $22.38 | +179.20% |
| May, 2028 | $22.33 | $19.50 | $23.52 | +180.54% |
| June, 2028 | $21.54 | $21.39 | $23.79 | +170.61% |
| July, 2028 | $19.43 | $19.10 | $21.70 | +144.10% |
| August, 2028 | $9.7471 | $8.9076 | $19.87 | +22.45% |
| September, 2028 | $8.9165 | $8.5318 | $9.6944 | +12.02% |
| October, 2028 | $5.806 | $5.3286 | $8.8939 | -27.06% |
| November, 2028 | $4.4028 | $4.2054 | $5.8233 | -44.69% |
| December, 2028 | $6.2623 | $4.2002 | $6.6249 | -21.33% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2029
The 2029 price forecast for Vir Biotechnology Inc Stock (VIR) is $32.99 on average, with a high prediction of $64.76 and a low estimate of $1.2078. This represents an +314.40% increase from the previous price of $7.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.6491 | $5.5544 | $7.1017 | -16.47% |
| February, 2029 | $6.0585 | $6.0385 | $7.4912 | -23.89% |
| March, 2029 | $5.888 | $5.013 | $6.6909 | -26.03% |
| April, 2029 | $7.8675 | $5.3404 | $8.6201 | -1.16% |
| May, 2029 | $6.0043 | $5.8643 | $8.4022 | -24.57% |
| June, 2029 | $5.1537 | $4.2964 | $6.5767 | -35.25% |
| July, 2029 | $4.1095 | $2.8457 | $5.94 | -48.37% |
| August, 2029 | $2.3331 | $1.8831 | $5.7136 | -70.69% |
| September, 2029 | $1.872 | $1.2078 | $3.6873 | -76.48% |
| October, 2029 | $6.0557 | $1.6415 | $8.2157 | -23.92% |
| November, 2029 | $7.1146 | $5.6954 | $18.71 | -10.62% |
| December, 2029 | $33.45 | $5.8393 | $64.76 | +320.27% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2030
Vir Biotechnology Inc Stock (VIR) is expected to reach an average price of $73.70 in 2030, with a high forecast of $131.57 and a low forecast of $15.83. This signifies an +825.85% surge from the last price of $7.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $19.37 | $16.97 | $43.81 | +143.31% |
| February, 2030 | $17.82 | $17.43 | $25.09 | +123.82% |
| March, 2030 | $24.16 | $17.95 | $32.37 | +203.58% |
| April, 2030 | $28.87 | $22.10 | $40.79 | +262.74% |
| May, 2030 | $38.18 | $25.62 | $44.34 | +379.62% |
| June, 2030 | $43.04 | $35.42 | $45.16 | +440.66% |
| July, 2030 | $22.97 | $17.39 | $43.29 | +188.57% |
| August, 2030 | $31.20 | $20.81 | $33.25 | +291.95% |
| September, 2030 | $22.81 | $19.59 | $34.30 | +186.53% |
| October, 2030 | $21.83 | $15.83 | $23.26 | +174.27% |
| November, 2030 | $17.25 | $17.11 | $24.58 | +116.72% |
| December, 2030 | $55.10 | $15.83 | $131.57 | +592.20% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):